Discontinued — last reported Q3 '16
Other
Remainder of Fiscal Year 2025
Medtronic Remainder of Fiscal Year 2025 decreased by 52.1% to $405.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.2%, from $414.00M to $405.00M. Over 5 years (FY 2020 to FY 2025), Remainder of Fiscal Year 2025 shows relatively stable performance with a -1.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ3 2016
Last reportedQ3 2016
Metric ID:
remainder_2025Historical Data
15 periods
| Q3 '21 | Q4 '21 | Q1 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.29B | $862.00M | $430.00M | $1.26B | $839.00M | $421.00M | $1.26B | $836.00M | $419.00M | $1.23B | $824.00M | $414.00M | $1.30B | $846.00M | $405.00M |
| QoQ Change | — | -33.0% | -50.1% | +193.3% | -33.5% | -49.8% | +198.3% | -33.4% | -49.9% | +192.8% | -32.8% | -49.8% | +214.7% | -35.1% | -52.1% |
| YoY Change | — | — | — | -1.9% | -2.7% | -2.1% | -0.4% | -0.4% | -0.5% | -2.3% | -1.4% | -1.2% | +6.2% | +2.7% | -2.2% |
Range$405.00M – $1.30B
CAGR-28.1%
Avg YoY Growth-0.5%
Median YoY Growth-1.3%
Current Streak2 quarters decline
Remainder of Fiscal Year 2025 at Other Companies
Frequently Asked Questions
- What is Medtronic's remainder of fiscal year 2025?
- Medtronic (MDT) reported remainder of fiscal year 2025 of $405.00M in Q1 2026.
- How has Medtronic's remainder of fiscal year 2025 changed year-over-year?
- Medtronic's remainder of fiscal year 2025 decreased by 2.2% year-over-year, from $414.00M to $405.00M.
- What is the long-term trend for Medtronic's remainder of fiscal year 2025?
- Over 5 years (2020 to 2025), Medtronic's remainder of fiscal year 2025 has grown at a -1.0% compound annual growth rate (CAGR), from $888.00M to $846.00M.